Phase 1 trial of a monoclonal antibody targeting the angiopoietin-like protein 3/8 complex in patients with mixed hyperlipidaemia

31 August 2025 (11:15 - 11:30)
Organised by: Logo
Congress Presentation Part of: Nature Medicine: 2025 highlights Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS) ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by